Suppr超能文献

初治个体对胆固醇及降脂药物的认知与了解:一项横断面研究

Perceptions and Knowledge of Cholesterol and Lipid-Lowering Medications Among Treatment-Naive Individuals: A Cross-Sectional Study.

作者信息

Kök Mehmet, Bostan Feyzi, Yacan Kök Ayşe

机构信息

Department of Internal Medicine, Antalya Training and Research Hospital of Ministry of Health, Antalya, Turkey.

Bucak Health School, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.

出版信息

Patient Prefer Adherence. 2025 May 13;19:1411-1422. doi: 10.2147/PPA.S511454. eCollection 2025.

Abstract

PURPOSE

The literature often includes studies on cholesterol perception and lipid-lowering medication (LLM) use with patients who have used or discontinued LLM for primary or secondary prevention. With the exponential rise in patients needing LLM each year, understanding their knowledge and perceptions of cholesterol and these drugs is crucial. For this reasons, we aimed to determine the perception and knowledge of treatment-naive participants about cholesterol and LLM.

PATIENTS AND METHODS

This cross-sectional study was conducted in Turkey between August 2020 and August 2022. A self-designed online survey developed from literature sources was used to determine the level of knowledge and perception of cholesterol, LLM and influencing factors.

RESULTS

A total of 2062 respondents completed the survey, which was sent to the participants via an online link. The most common sources of information about cholesterol and lipid-lowering medications were medical staff (71%) media (58.4%) and scientific publications (33.3%). The most three common factors affecting the participants' perception of cholesterol and LLM were medical staff (49.6%), media (23.7%), and scientific publications (15.6%).

CONCLUSION

Our study revealed that participants have some inaccurate and incomplete information about cholesterol and LLM. Medical staff and the media emerged as the primary sources of information and crucial influences on most participants' perceptions of cholesterol and LLM.

摘要

目的

文献中经常包含对已使用或停用降脂药物(LLM)进行一级或二级预防的患者的胆固醇认知和降脂药物使用情况的研究。随着每年需要使用降脂药物的患者数量呈指数级增长,了解他们对胆固醇和这些药物的知识及认知至关重要。出于这个原因,我们旨在确定初治参与者对胆固醇和降脂药物的认知和知识水平。

患者与方法

这项横断面研究于2020年8月至2022年8月在土耳其进行。采用从文献来源开发的自行设计的在线调查问卷,以确定对胆固醇、降脂药物及其影响因素的知识和认知水平。

结果

共有2062名受访者完成了通过在线链接发送给参与者的调查问卷。关于胆固醇和降脂药物最常见的信息来源是医务人员(71%)、媒体(58.4%)和科学出版物(33.3%)。影响参与者对胆固醇和降脂药物认知的最常见的三个因素是医务人员(49.6%)、媒体(23.7%)和科学出版物(15.6%)。

结论

我们的研究表明,参与者对胆固醇和降脂药物有一些不准确和不完整的信息。医务人员和媒体成为主要的信息来源,并对大多数参与者对胆固醇和降脂药物的认知产生关键影响。

相似文献

1
Perceptions and Knowledge of Cholesterol and Lipid-Lowering Medications Among Treatment-Naive Individuals: A Cross-Sectional Study.
Patient Prefer Adherence. 2025 May 13;19:1411-1422. doi: 10.2147/PPA.S511454. eCollection 2025.
8
Impact of lipid-lowering medications and low-density lipoprotein levels on 1-year clinical outcomes after coronary artery bypass grafting.
J Am Coll Surg. 2013 Sep;217(3):452-60. doi: 10.1016/j.jamcollsurg.2013.04.030. Epub 2013 Jul 25.

本文引用的文献

1
Cerebrovascular Disease and Statins.
Front Cardiovasc Med. 2021 Dec 2;8:778740. doi: 10.3389/fcvm.2021.778740. eCollection 2021.
2
Impact of Adherence, Patient Perception, and Knowledge to Statin Therapy - A Cross-Sectional Study.
Indian J Endocrinol Metab. 2021 May-Jun;25(3):206-210. doi: 10.4103/ijem.ijem_120_21. Epub 2021 Oct 26.
3
Statins in a Distorted Mirror of Media.
Curr Atheroscler Rep. 2020 Jun 18;22(8):37. doi: 10.1007/s11883-020-00853-9.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验